Capital Markets Day

RNS Number : 5049V
Gooch & Housego PLC
09 April 2019
 

For immediate release

 9 April 2019

 

 

 

 

Gooch & Housego PLC

("Gooch & Housego" or the "Company")

 

Capital Markets Day

 

 

Gooch & Housego PLC (AIM: GHH), the specialist manufacturer of optical components and systems, announces that it is holding a Capital Markets Day for institutional investors and analysts later today.

The event will be focused on "Markets and Technology":

 

·  "Markets" will cover the three market sectors of Industrials, Aerospace & Defence and Life Sciences/Biophotonics.

 

·      "Technology" will feature technology trends and roadmaps, brought to life with case studies in areas such as Space Photonics and Biophotonics.

 

Members of G&H's senior management team will be in attendance.

 

The presentation will be available by close of business on the Company's website at https://goochandhousego.com/investors/investors-presentations/.

 

G&H has today released, by separate announcement, its scheduled Half Year Trading Update. No new material information on current trading and outlook will be provided at today's Capital Markets Day. 

 

 

For further information contact: -

 

 

 

Mark Webster / Andrew Boteler 

Gooch & Housego PLC

01460 256440

Mark Court / Sophie Wills / Catriona Flint

Buchanan

020 7466 5000

Patrick Robb / David Anderson   

Investec Bank plc

020 7597 5970

 

 

 

Notes to editors

 

Gooch & Housego is a photonics technology business headquartered in Ilminster, Somerset, UK with operations in the USA and Europe. A world leader in its field, the company researches, designs, engineers and manufactures advanced photonic systems, components and instrumentation for applications in the Aerospace & Defence, Industrial, Life Sciences and Scientific Research sectors. World leading design, development and manufacturing expertise is offered across a broad range of complementary technologies.

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCUGUWCCUPBGRR
UK 100

Latest directors dealings